Details of Disease

Disease Name

Malignant solid tumour

Disease Class

2A00-2F9Z: Solid tumour/cancer

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISITUVU: Malignant solid tumour

ICD-11

ICD-11: 2C10-2F32

ICD-10

ICD-10: C76-C80

ICD-9

ICD-9: 140-199

Expand ICD-11

'2D4Z

Expand ICD-10

'C76-C80; 'C76; 'C76.0; 'C76.1; 'C76.2; 'C76.3; 'C76.4; 'C76.5; 'C76.7; 'C76.8; 'C80; 'C80.0; 'C80.9

Expand ICD-9

1.40E+179

General Information of Disease (ID: DISITUVU)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Pegfilgrastim	DM7UP8X	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
S-222611	DMQGH76	Phase 1b	NA	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6969).
2	Clinical pipeline report, company report or official report of Shionogi (2011).